Raising from Cantos? See their portfolio and how founders fare.
Free to see. No signup.
Cantos is on record against 38 companies, each listed on its own site.
8 of these companies have a funding record on file.
Cantos has 4 venture fund vehicles on file with the SEC, run from San Francisco, California, with first sales running from 2024 to 2026. 4 Form D notices, originals and amendments, have been filed for them, the first on November 15, 2024 and the latest on September 9, 2026. Together they have taken in $5,634,301 from 13 investor positions, most recently on September 4, 2026. The smallest investment any of them will accept is $1,000, rising to $200,000. One vehicle is still showing room to take more.
| Vehicle | Vintage | Target | Closed | Remaining | First sale | Days | Min check | LPs | Status |
|---|---|---|---|---|---|---|---|---|---|
Canto of Plymouth, a series of Cantos Fund, LP Filing: Form D, September 9, 2026 |
2026 | $3M | $3M | — | September 4, 2026 | 54 | $100K | 7 | fully sold |
Canto of Jupiter III, a series of Cantos Fund, LP Filing: Form D, September 1, 2026 |
2026 | $800K | $800K | — | August 24, 2026 | 65 | $1K | 2 | fully sold |
Canto of Arcadia, a series of Cantos Fund, LP Filing: Form D, August 4, 2026 |
2026 | $1.8M | $1.8M | — | July 31, 2026 | 89 | $200K | 4 | fully sold |
Cantos Ventures IV, L.P. Filing: Form D, November 15, 2024 |
2024 | no cap set | — | — | — | — | — | 0 | open |
The filings for these vehicles name 2 people and entities, with the role each filing gives.
Cantos is an early-stage venture firm that positions itself as a first-money-in partner for technically ambitious founders working to transform the physical world. The firm's stated focus spans sectors including energy, defense, infrastructure, space, and advanced manufacturing, with a deliberate appetite for underwriting high technical and regulatory risk at the earliest stages of company formation. The firm's portfolio reflects this orientation across a broad range of hard-technology and science-driven ventures. Companies such as Opus 12, Solugen, and Visolis point to a sustained interest in novel chemistry and materials. Dusty Robotics, ALICE Technologies, and Standard Cyborg suggest engagement with robotics and physical automation. SkyRyse and Interstellar indicate exposure to aerospace and next-generation aviation. Prellis Biologics extends the portfolio into advanced biological manufacturing. Arable and AgriData reflect attention to agricultural technology, while Stronghold and Patch signal interest in energy and climate infrastructure. Alongside these deep-technology bets, Cantos has also backed fintech and data infrastructure companies including Dharma Labs, Qwil, Ethic, and Shipamax, as well as health-focused ventures such as Helium Health and Ava, suggesting a founder-first orientation that occasionally follows exceptional technical teams across adjacent domains. Taken together, the portfolio reveals a firm that prioritizes scientific and engineering ambition, backs founders confronting complex regulatory and technical barriers, and seeks to engage at the earliest possible moment in a company's development.
Each opens in a new tab, filled in for Cantos. With no account yet, you sign up free and land on the result.
https://mentionfox.com/investors/cantos